Image
Image
Image 3
Image 3
Image 10
Image 10
Image 11
Image 11
Image 12
Image 12
Image 13
Image 13
Jugular paragangliomas are the most common tumors of the jugular fossa despite being rare overall, with up to 10% of patients having bilateral or multiple paragangliomas.
The clinical presentation depends on the degree of middle ear involvement, ranging from asymptomatic incidental findings to pulsatile tinnitus and hearing loss when significant middle ear involvement is present.
Multiple cranial nerve syndromes can result from tumor involvement of structures at the jugular foramen, including Vernet syndrome (CN IX, X, XI), Collet-Sicard syndrome (CN IX, X, XI, XII), and Horner syndrome (CN XII).
Surgery is the definitive treatment with cure expected after complete resection, but recurrence and local invasion occur in 40-50% of cases, requiring long-term surveillance.
Base of skull paragangliomas such as jugular paragangliomas are radiosensitive, making radiotherapy an effective treatment option for large inoperable tumors or medically frail patients, in contrast to the relative radioresistance of cervical paragangliomas.
Preoperative DSA with embolization 1-2 days prior to surgery reduces operative blood loss by occlusion of feeding vessels, but requires expertise in regional vascular anatomy to avoid complications.
Describe the lesion as a hypervascular mass at the jugular foramen with salt and pepper signal characteristics on MRI, intense post-gadolinium enhancement, moth-eaten irregular bone erosion on CT, and specify the direction of extension (superior to mastoid air cells/middle ear, inferior to infratemporal fossa) and presence of any associated cranial nerve involvement, then recommend DSA for vascular characterization and preoperative planning.